Literature DB >> 7027178

[Superficial herpes simplex keratitis. Double-blind comparative trial of acyclovir and idoxuridine (author's transl)].

J Colin, A Tournoux, C Chastel, G Renard.   

Abstract

In a double-blind, randomized trial 52 patients with superficial herpes simplex keratitis were treated with a new antiviral compound, acylclovir (ACV) 3% ointment, or with idoxuridine (IDU) 0.5% ointment. No statistically significant difference was found in the number of patients cured with either drug, but healing was achieved more rapidly with ACV than with IDU.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7027178

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  15 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

2.  Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.

Authors:  H B Hoh; C Hurley; C Claoue; M Viswalingham; D L Easty; P Goldschmidt; L M Collum
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

3.  Oral acyclovir in the management of dendritic herpetic corneal ulceration.

Authors:  S O Hung; A Patterson; D I Clark; P J Rees
Journal:  Br J Ophthalmol       Date:  1984-06       Impact factor: 4.638

4.  Functional differences in nucleoside and nucleobase transporters expressed on the rabbit corneal epithelial cell line (SIRC) and isolated rabbit cornea.

Authors:  Soumyajit Majumdar; Giridhar S Tirucherai; Dhananjay Pal; Ashim K Mitra
Journal:  AAPS PharmSci       Date:  2003

5.  Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration.

Authors:  L M Collum; P McGettrick; J Akhtar; J Lavin; P J Rees
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

6.  Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.

Authors:  Joseph Colin
Journal:  Clin Ophthalmol       Date:  2007-12

7.  Pharmacokinetics of oral acyclovir (Zovirax) in the eye.

Authors:  S O Hung; A Patterson; P J Rees
Journal:  Br J Ophthalmol       Date:  1984-03       Impact factor: 4.638

Review 8.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

9.  Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration.

Authors:  L M Collum; P Logan; D McAuliffe-Curtin; S O Hung; A Patterson; P J Rees
Journal:  Br J Ophthalmol       Date:  1985-11       Impact factor: 4.638

10.  Acyclovir treatment in stromal herpetic keratitis.

Authors:  J A Oosterhuis; R van Ganswijk; J Versteeg
Journal:  Doc Ophthalmol       Date:  1983-12-15       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.